We previously assessed the function of Cx32 in liver diseases via the establishment of Cx32 dominant negative transgenic (Cx32ΔTg) rats with a dominant negative mutant of Cx32 controlled by an albumin (Alb) promoter [12]. The gene discussed is ALB; the disease is liver disorder.